Page last updated: 2024-08-22

poloxalene and Alloxan Diabetes

poloxalene has been researched along with Alloxan Diabetes in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eissa, LA; El Gayar, AM; El-Far, YM; El-Sherbiny, IM; Gabr, MM; Zakaria, MM	1
Li, YP; Li, ZL; Liu, ZY; Tam, KC; Xie, GX; Xiong, XY; Zhou, CL	1

Other Studies

2 other study(ies) available for poloxalene and Alloxan Diabetes

Article	Year
A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes. Nanomedicine (London, England), 2016, Volume: 11, Issue:19 Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Micelles; Nanoparticles; Oxidative Stress; Pancreas; Particle Size; Peptide Fragments; Plant Extracts; Poloxalene; Rats, Sprague-Dawley; Silymarin; Tissue Distribution	2016
Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. Journal of controlled release : official journal of the Controlled Release Society, 2007, Jul-16, Volume: 120, Issue:1-2 Topics: Administration, Oral; Animals; Blood Glucose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Feasibility Studies; Hypoglycemic Agents; Insulin; Kinetics; Male; Mice; Nanoparticles; Poloxalene; Polyesters; Solubility	2007

Article

Year

A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes.

Nanomedicine (London, England), 2016, Volume: 11, Issue:19

Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Micelles; Nanoparticles; Oxidative Stress; Pancreas; Particle Size; Peptide Fragments; Plant Extracts; Poloxalene; Rats, Sprague-Dawley; Silymarin; Tissue Distribution

2016

Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.

Journal of controlled release : official journal of the Controlled Release Society, 2007, Jul-16, Volume: 120, Issue:1-2

Topics: Administration, Oral; Animals; Blood Glucose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Feasibility Studies; Hypoglycemic Agents; Insulin; Kinetics; Male; Mice; Nanoparticles; Poloxalene; Polyesters; Solubility

2007